| Notes to the financial statements | Note 4 |
|
| COMPANY |
|
|
|
GROUP |
|
| 2016 |
|
|
2015
Restated* |
|
|
(R’million) |
2016 |
|
|
2015
Restated*# |
|
| |
|
|
|
|
4 |
Operating income/(loss) before impairments and abnormal items |
|
|
|
|
|
| |
|
|
|
|
4.1 |
Operating income/(loss) has been
determined after charging/(crediting): |
|
|
|
|
|
| |
|
|
|
|
|
External auditors’ remuneration |
34,5 |
|
|
31,0 |
|
| |
|
|
|
|
|
– Audit fees |
29,8 |
|
|
27,2 |
|
| |
|
|
|
|
|
– Other fees and expenses |
4,7 |
|
|
3,8 |
|
| |
|
|
|
|
|
Internal auditors’ remuneration |
14,0 |
|
|
10,8 |
|
| |
|
|
|
|
|
Depreciation |
558,8 |
|
|
517,8 |
|
| |
|
|
|
|
|
– On buildings |
61,0 |
|
|
55,0 |
|
| |
|
|
|
|
|
– On plant, equipment and vehicles |
495,8 |
|
|
460,0 |
|
| |
|
|
|
|
|
– On capitalised leased assets |
2,0 |
|
|
2,8 |
|
| |
|
|
|
|
|
Amortisation |
11,9 |
|
|
23,8 |
|
| |
|
|
|
|
|
– On trademarks, licence agreements and other intangibles |
11,4 |
|
|
19,2 |
|
| |
|
|
|
|
|
– On customer lists |
0,5 |
|
|
4,6 |
|
| |
|
|
|
|
|
Operating lease charges |
198,2 |
|
|
169,8 |
|
| |
|
|
|
|
|
– On land and buildings |
71,2 |
|
|
60,3 |
|
| |
|
|
|
|
|
– On plant, equipment and vehicles |
127,0 |
|
|
109,5 |
|
| |
|
|
|
|
|
Loss on disposal of plant, equipment and vehicles |
0,2 |
|
|
1,1 |
|
| |
|
|
|
|
|
Research, development and related expenditure |
15,6 |
|
|
23,6 |
|
| |
|
|
|
|
|
IFRS 2 charges |
88,9 |
|
|
29,2 |
|
| |
|
|
|
|
|
– Cash settled |
18,0 |
|
|
(60,9) |
|
| |
|
|
|
|
|
– Equity settled, including BEE-related IFRS 2 expenses |
70,9 |
|
|
90,1 |
|
| |
|
|
|
|
|
Staff costs |
3 318,1 |
|
|
3 019,9 |
|
| |
|
|
|
|
|
Employer’s contribution to retirement funding |
243,3 |
|
|
217,7 |
|
| |
|
|
|
|
|
Employer’s contribution to medical aid |
90,9 |
|
|
88,2 |
|
| 5,7 |
|
|
(10,4) |
|
|
Foreign exchange loss/(profit) |
27,3 |
|
|
(63,5) |
|
| |
|
|
|
|
4.2 |
Directors’ emoluments |
|
|
|
|
|
| |
|
|
|
|
|
Executive directors |
|
|
|
|
|
| |
|
|
|
|
|
– Salaries and bonuses |
18,8 |
|
|
18,2 |
|
| |
|
|
|
|
|
– Retirement, medical and other benefits |
49,3 |
|
|
8,9 |
|
| |
|
|
|
|
|
Non-executive directors |
|
|
|
|
|
| 7,8 |
|
|
6,7 |
|
|
– Fees |
7,8 |
|
|
6,7 |
|
| 7,8 |
|
|
6,7 |
|
|
Total directors’ emoluments |
75,9 |
|
|
33,8 |
|
| |
|
|
|
|
|
Less: Paid by subsidiaries |
(68,1) |
|
|
(27,1) |
|
| 7,8 |
|
|
6,7 |
|
|
Emoluments paid by company |
7,8 |
|
|
6,7 |
|
| |
|
|
|
|
|
For more details refer to Annexure C. |
|
|
|
|
|
| * |
The comparatives have been restated for the retrospective reclassification relating to the treatment of foreign exchange profits and losses
on foreign cash balances and loans of a funding nature previously included in operating income/(loss) and now reclassified to net finance
costs. Refer to note 7 for further details. |
| # |
Restated as required by IFRS 5 in relation to the treatment of Tiger Branded Consumer Goods plc (TBCG) as a discontinued operation. |
| Notes to the financial statements | Note 4 |
|
|